Philips introduces IntraSight Plus interventional platform
Philips has launched the IntraSight Plus coronary interventions platform, which is cleared for clinical use in Europe and the US.…
News
C4 Therapeutics begins dosing in Phase Ib trial for multiple myeloma
Daiichi Sankyo and Tempus AI collaborate on ADC clinical development
Neurovalens receives EU MDR compliance for sleep insomnia device
IASO Bio secures approval for cell therapy trial in Japan
MSD and Quotient collaborate on IBD drug targets
Samsung Medison to unify US medical imaging units
Sensorion reports six-month Audiogene trial results for gene therapy
